IsamAliAbdel-KarimMDMSc, MHA

Attending physician, Department of Hematology and Oncology/Cancer Care Associates

Dr. Abdel-Karim is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
7301 Rogers Ave
Fort Smith, AR 72903
Phone+1 479-274-6200

Fax+1 479-274-6299

University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 2005 - 2008
University of Texas Health Science Center - San AntonioMaster of Science in clinical invesitigation, 2004 - 2007
University of Texas Health Science Center - San AntonioMaster of Science in clinical invesitigation, 2004 - 2007
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hospice and Palliative Medicine, 2004 - 2005
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Geriatric Medicine (Internal Medicine), 2003 - 2004
St Vincent Charity Medical CenterResidency, Internal Medicine, 2000 - 2003
University of Jordan Faculty of MedicineClass of 1998

PubMed

6 citations
A phase I study of pemetrexed in patients with relapsed or refractory acute leukemia
Isam A. Abdel-Karim, William Plunkett, Susan O'Brien, Francis J. Giles, Deborah A. Thomas
Investigational New Drugs. 2011-04-01
9 citations
Mammalian target of rapamycin as a target in hematological malignancies.
Isam A. Abdel-Karim, Francis J. Giles
Current Problems in Cancer. 2008-07-01
20 citations
Causes of death at autopsy in an inpatient hospice program.
Isam A. Abdel-Karim, Robert B. Sammel, Mark A. Prange
Journal of Palliative Medicine. 2007-09-05